Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.
スポンサーリンク
概要
- 論文の詳細を見る
We conducted combination therapy with cyclophosphamide, vincristine, and dacarbazine (CVD) for recurrent malignant pheochromocytoma. A 41-year-old woman with ectopic malignant pheochromocytoma had metastases to the liver and left cervical lymph node 7 months after removal of theprimary lesion. At the beginning of October 1999, she was treated with fhe CVD regimen. After 3 courses of chemotherapy, metastases disappeared and urinary catecholamine decreased to normal levels. Only serum noradrenalin was not normalized by the end of treatment. Nine months later, computed tomography (CT) scans of the cervix andabdomen showed recurrent tumors. The woman was treated with the CVD regimen again, but tumor size and biochemical tumor markers remained unchanged. The CVD regimen was thus effective as a primary treatment for malignant pheochiromocytoma with metastases.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.